logo
How To Lead A Company Through Personal Crisis And Come Back Stronger

How To Lead A Company Through Personal Crisis And Come Back Stronger

Forbes21 hours ago

As Paramount Chair Shari Redstone reveals her battle with thyroid cancer, founder Billie Whitehouse opens up about leading a company through a profound health challenge—and what other women leaders can learn from her experience.
When news broke that Shari Redstone, Chair of Paramount Global, is undergoing treatment for thyroid cancer, the public learned only through a brief, formal statement from her spokesperson. Redstone has not commented directly but emphasized through her team that she would 'maintain all professional and philanthropic activities throughout her treatment, which is ongoing.' Her discretion underscores the pressure many women leaders face to project invulnerability in the face of deeply personal health crises.
That's why Billie Whitehouse, founder and CEO of fashion tech company Wearable X, is choosing a different path. Now in remission after a stage 4 colon cancer diagnosis, she's sharing what she wishes she had known—and how women can remain effective leaders through profound health challenges.
When Whitehouse was initially diagnosed in 2022, she was 27 years old and 22 weeks pregnant. Despite experiencing intense abdominal pain, her doctors repeatedly dismissed her concerns.
'They kept telling me that it didn't make sense for me to get a colonoscopy and that I didn't fit the profile. I wish I could have read something somewhere that showed me what I should have done. At the time, I didn't have the confidence to push back. I was just like, 'oh yeah, they're the experts. Okay, we move on.''
Eventually, emergency surgery revealed a tumor in her transverse colon. Her baby survived the operation but died six days later.
Whitehouse took a board meeting from the hospital the day before her baby died. 'I had waited for this board meeting for so long. Everyone had rescheduled a million times. I just needed to get it done. In hindsight, I really wish I hadn't done that.'
Her experience and her survival taught her powerful lessons she now wants to share with other women. She hopes her story can guide those navigating personal crises while also leading companies.
Whitehouse's first instinct was to keep her diagnosis private. And she doesn't regret it.
'I told [the board] I was going through treatment, but not what the treatment was,' she says. 'I feared not getting a project or a client because someone thought I was too high-risk. I was worried they would remove me if they didn't think I could do the job.'
John Samuels, CEO of Wellworth Advisors, agrees that leaders don't always have to disclose all of the personal details. However, they do need a plan. He suggests considering factors like privacy, the ability to perform your job, the type of work you do and legal and regulatory requirements. Samuels also suggests only communicating facts and not 'unknowns.'
While Whitehouse kept her personal story to herself, she did choose to over-communicate about the state of the company. 'In the first month after my diagnosis, we lost our biggest client, our bank went bust and we got audited for our insurance,' she says. 'So, I really over communicated with the board at that time.'
When asked if she felt that was the right approach, she answered an emphatic yes. 'The board has since told me they were so grateful for the over communication.'
Nadi X by Wearable X yoga wear
Wearable X
When Whitehouse was first diagnosed, she tried to maintain a sense of normalcy, prioritizing both work and her health, despite undergoing surgery and a rigorous course of chemotherapy. She didn't want to convey that she wasn't able to do her job. 'In the first three months of my diagnosis, I tried to maintain my normal work schedule. I tried to be on every call and just 'do the thing.''
Melissa Gonzalez, author of The Purpose Pivot, says women need to stop looking at vulnerability as a weakness. 'Too often, in our personal pursuit of professional excellence, especially as women leaders, we've been conditioned to ignore the early warning signs our bodies send us.' The retail strategist says women are conditioned to wear exhaustion like a 'badge of honor.' 'We hide our struggles out of fear of appearing weak and tell ourselves to just 'power through' until our bodies make different decisions for us.'
Lisa Marchiano agrees, especially for younger women. The Jungian analyst and podcaster says, 'Young women in a corporate environment often worry about not being taken seriously. Showing weakness or vulnerability may feel unthinkable as they worry it will undermine their authority.'
When Whitehouse's cancer returned in 2023, she took a different approach.
Whitehouse's recurrence provided an opportunity to do things differently. She says one of her biggest realizations was that she didn't need to keep pushing at full speed. She could, and should, set boundaries.
Referring to her second bout with colon cancer, Whitehouse said, 'This time I was just very deliberate about when I could work and when I couldn't based on my treatment. I told people I would respond by email, but slowly... don't expect it to be immediate.'
Whitehouse says she learned this lesson the hard way.
'Previously I tried to maintain my normal work schedule. This time around, it was a much more deliberate approach.'
Marchiano warns that bearing suffering alone cuts us off from an essential source of help and comfort. Women, fortunately, tend to respond to stress through a strategy known as 'tend and befriend,' she says. 'If we're suffering, we let our close circle know and may receive an outpouring of material and emotional support.' However, she warns, if we choose to keep a diagnosis private at work, we lack that support where we may need it the most.
This means it may be helpful to confide in a close circle of colleagues.
'Having to face a life-threatening illness or devastating loss while few around have any idea means that you are carrying this burden alone, at least in the work sphere,' Marchiano says. 'This takes a toll.'
'I got my mojo back by finding things to look forward to, like meaningful projects, travel, time with family,' says Whitehouse.
'I'm enjoying work in a new way at the moment,' she says. 'And I think that helps you get your mojo back—when you can find the parts of work that really excite you.'
That also includes getting rid of toxic clients. After engaging with a client that caused her a great deal of stress, she ended the relationship. 'I'm proud of myself for making that decision. The stress from working with people like that is too great now.'
Whitehouse has also launched a yoga e-book and is developing a breast pad that vibrates to reduce mastitis in nursing mothers.
And her biggest boss move yet may just be her recent photoshoot that shows the world her battle wounds – her surgical scars. 'It's quite personal,' she explains. 'But it feels like it's the time to be fully transparent.'
'One of the things we need to do with suffering is to make meaning of it,' says Marchiano. 'Then, it can become bearable.' Marchiano supports Whitehouse sharing her story so that others going through something similar might benefit. 'In this way, she is trying to put her suffering to good purpose.'
Gonzalez shares the same sentiment. One recurring theme she elicited through interviews for her book is about sharing. 'There is immense relief that comes from sharing our journeys and embracing the strength found in vulnerability, and the unexpected gift of our sharing helping others.'
Whitehouse agrees. 'I've decided I don't want to be ruled by fear anymore,' she says. 'I want to live fully, and for me, that means being vocal.'
Whitehouse's Nadi X yoga wear by Wearable X
Wearable X
And vocal she is. While not every woman will or should handle crises in the workplace the same way, what matters is that your communication be honest and on your own terms.
'Communicate authentically to yourself,' Whitehouse says. 'For me, that meant ensuring that the status of the company was clear and that there was still a path to success—even if that meant taking some time to slow down.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Kennedy's HHS sent Congress ‘junk science' to defend vaccine changes, experts say
Kennedy's HHS sent Congress ‘junk science' to defend vaccine changes, experts say

CNN

time23 minutes ago

  • CNN

Kennedy's HHS sent Congress ‘junk science' to defend vaccine changes, experts say

Vaccines Federal agencies Congressional news Respiratory virusesFacebookTweetLink Follow A document the Department of Health and Human Services sent to lawmakers to support Secretary Robert F. Kennedy Jr.'s decision to change U.S. policy on covid vaccines cites scientific studies that are unpublished or under dispute and mischaracterizes others. One health expert called the document 'willful medical disinformation' about the safety of covid vaccines for children and pregnant women. 'It is so far out of left field that I find it insulting to our members of Congress that they would actually give them something like this. Congress members are relying on these agencies to provide them with valid information, and it's just not there,' said Mark Turrentine, a professor of obstetrics and gynecology at Baylor College of Medicine. Kennedy, who was an anti-vaccine activist before taking a role in the Trump administration, announced May 27 that the Centers for Disease Control and Prevention would no longer recommend covid vaccines for pregnant women or healthy children, bypassing the agency's formal process for adjusting its vaccine schedules for adults and kids. The announcement, made on the social platform X, has been met with outrage by many pediatricians and scientists. The HHS document meant to support Kennedy's decision, obtained by KFF Health News, was sent to members of Congress who questioned the science and process behind his move, according to one federal official who asked not to be identified because he wasn't authorized to discuss the matter publicly. The document has not been posted on the HHS website, though it is the first detailed explanation of Kennedy's announcement from the agency. Titled 'Covid Recommendation FAQ,' the document distorts some legitimate studies and cites others that are disputed and unpublished, medical experts say. HHS director of communications Andrew Nixon told KFF Health News, 'There is no distortion of the studies in this document. The underlying data speaks for itself, and it raises legitimate safety concerns. HHS will not ignore that evidence or downplay it. We will follow the data and the science.' HHS did not respond to a request to name the author of the document. One of the studies the HHS document cites is under investigation by its publisher regarding 'potential issues with the research methodology and conclusions and author conflicts of interest,' according to a link on the study's webpage. 'This is RFK Jr.'s playbook,' said Sean O'Leary, chair of the Committee on Infectious Diseases for the American Academy of Pediatrics and an assistant professor of pediatrics at the University of Colorado School of Medicine. 'Either cherry-pick from good science or take junk science to support his premise — this has been his playbook for 20 years.' Another study cited in the document is a preprint that has not been peer-reviewed. Under the study's title is an alert that 'it reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.' Though the preprint was made available a year ago, it has not been published in a peer-reviewed journal. The FAQ supporting Kennedy's decision claims that 'post-marketing studies' of covid vaccines have identified 'serious adverse effects, such as an increased risk of myocarditis and pericarditis' — conditions in which the heart's muscle or its covering, the pericardium, suffer inflammation. False claims that the 2024 preprint showed myocarditis and pericarditis only in people who received a covid vaccine, and not in people infected with covid, circulated on social media. One of the study's co-authors publicly rejected that idea, because the study did not compare outcomes between people who were vaccinated and those infected with the covid virus. The study also focused only on children and adolescents. The HHS document omitted numerous other peer-reviewed studies that have shown that the risk of myocarditis and pericarditis is greater after contracting covid for both vaccinated and non-vaccinated people than the risk of the same complications after vaccination alone. O'Leary said that while some cases of myocarditis were reported in vaccinated adolescent boys and young men early in the covid pandemic, the rates declined after the two initial doses of covid vaccines were spaced further apart. Now, adolescents and adults who have not been previously vaccinated receive only one shot, and myocarditis no longer shows up in the data, O'Leary said, referring to the CDC's Vaccine Safety Datalink. 'There is no increased risk at this point that we can identify,' he said. In two instances, the HHS memo makes claims that are actively refuted by the papers it cites to back them up. Both papers support the safety and effectiveness of covid vaccines for pregnant women. The HHS document says that another paper it cites found 'an increase in placental blood clotting in pregnant mothers who took the vaccine.' But the paper doesn't contain any reference to placental blood clots or to pregnant women. 'I've now read it three times. And I cannot find that anywhere,' said Turrentine, the OB-GYN professor. If he were grading the HHS document, 'I would give this an 'F,'' Turrentine said. 'This is not supported by anything and it's not using medical evidence.' While members of Congress who are physicians should know to check references in the paper, they may not take the time to do so, said Neil Silverman, a professor of clinical obstetrics and gynecology who directs the Infectious Diseases in Pregnancy Program at the David Geffen School of Medicine at UCLA. 'They're going to assume this is coming from a scientific agency. So they are being hoodwinked along with everyone else who has had access to this document,' Silverman said. The offices of three Republicans in Congress who are medical doctors serving on House and Senate committees focused on health, including Sen. Bill Cassidy (R-La.), did not respond to requests for comment about whether they received the memo. Emily Druckman, communications director for Rep. Kim Schrier (D-Wash.), a physician serving on the House Energy and Commerce Committee, confirmed that Schrier's office did receive a copy of the document. 'The problem is a lot of legislators and even their staffers, they don't have the expertise to be able to pick those references apart,' O'Leary said. 'But this one — I've seen much better anti-vaccine propaganda than this, frankly.' C.J. Young, deputy communications director for the House Energy and Commerce Committee, confirmed that Democratic staff members of the committee received the document from HHS. In the past, he said, similar documents would help clarify the justification and scope of an administration's policy change and could be assumed to be scientifically accurate, Young said. 'This feels like it's breaking new ground. I don't think that we saw this level of sloppiness or inattention to detail or lack of consideration for scientific merit under the first Trump administration,' Young said. On June 4, Rep. Frank Pallone (D-N.J.) and Schrier introduced a bill that would require Kennedy to adopt official vaccine decisions from the Advisory Committee on Immunization Practices, or ACIP. Young said the motivation behind the bill was Kennedy's decision to change the covid vaccine schedule without the input of ACIP's vaccine experts, who play a key role in setting CDC policies around vaccine schedules and access. Kennedy announced June 9 on X that he would remove all 17 members of ACIP, citing alleged conflicts of interest he did not detail, and replace them. He announced eight replacements June 11, including people who had criticized vaccine mandates during the covid pandemic. KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF — the independent source for health policy research, polling, and journalism.

Colon Cancer Cases Are Rising. Here's How To Get Screened.
Colon Cancer Cases Are Rising. Here's How To Get Screened.

Forbes

time32 minutes ago

  • Forbes

Colon Cancer Cases Are Rising. Here's How To Get Screened.

Photo of person getting colon cancer screening Colon cancer is a leading cause of cancer-related deaths. It typically begins as a small growth of tissue called a polyp in the lining of the colon or rectum. While not all polyps become cancerous, most colon cancers start as polyps, making early detection and removal critical. Fortunately, colon cancer is highly preventable and survivable. Regular screening plays a key role in identifying and removing precancerous polyps and early-stage cancers, when treatment is most effective. In fact, 9 out of 10 people survive when colon cancer is found early. Without screening, undetected cancers can progress to advanced stages, such as Stage III and IV, which are associated with poorer outcomes. Colorectal cancer is projected to claim 53,000 lives in 2025. Understanding your colon cancer screening options will allow you to make informed choices alongside your clinician. The American Cancer Society now recommends that individuals at average risk begin regular colon cancer screening at age 45, a shift from the previous benchmark of 50. The lowered screening age reflects rising rates of colon cancer in younger adults and historically low screening compliance for older adults. You may need to start earlier than 45 if you have: As an example, if your sibling was diagnosed with Stage 1 colon cancer at age 40, you wouldn't wait until 45 for your first colonoscopy. Instead, you'd start 10 years before their diagnosis—at age 30. Given how risk factors change one's initial screening age it is of critical importance for individuals to know their personal and family history when speaking with their clinician about initial screening. Reminder on to do list to schedule a colonoscopy 1. Colonoscopy What it is: A procedure that uses a flexible tube with a camera to examine the entire colon. If polyps are found, they can be removed during the procedure. 'A colonoscopy is the gold standard and most preferred method because we can examine the entire colon, locate where the early growths (polyps) are, and remove them on the spot. This is what makes a colonoscopy a cancer prevention procedure," says Dr. Austin Chiang, Gastroenterologist and author of Gut: An Owner's Guide. Other details: This procedure requires patients to undergo preparation (e.g. dietary modifications and laxatives) beforehand to clear the colon so that there is adequate visualization. Since it is performed under sedation most people experience little to no discomfort and have no memory of the exam. The entire process usually takes less than an hour. 2. Flexible Sigmoidoscopy What it is: A flexible sigmoidoscopy examines only part of the colon, called the sigmoid colon, where colorectal cancer is commonly found. 'Some prefer this method because it doesn't require drinking a full bowel prep, but the tradeoff is that most of the colon is left unexamined," says Chiang. Other details: Flexible sigmoidoscopy often uses lighter sedation or none at all. Some patients may experience mild cramping during the approximately 20-minute procedure. While less comprehensive than a full colonoscopy, it can be a more convenient option for some. 3. CT Colonography What it is: A CT scan that produces 3D images of the colon and rectum to identify abnormalities. However, 'if any abnormalities are found, a traditional colonoscopy is still required for further evaluation or removal, ' says Chiang. Other details: It exposes patients to a low dose of radiation and is best at detecting larger polyps (>1cm). Thus smaller polyps may go undetected. 4. Capsule Endoscopy (e.g. Pill Endoscopy) Camera capsule for intestinal examination What it is: A swallowable capsule with a tiny camera that takes thousands of pictures as it travels through the digestive tract. 'Capsule endoscopy can be used to visualize the colon only after incomplete or inadequate colonoscopy. Like other non-invasive tests, including CT colonography, no intervention can be performed during the test,' says Chiang. Other details: Capsule endoscopy is painless and does not require sedation, but preparation is similar to that for a colonoscopy. The images are transported to an external wearable device and the capsule does not need to be returned. This test's accuracy can vary based on preparation of bowel. It cannot remove polyps. 5. Fecal Immunochemical Test (FIT) What it is: A stool test that detects hidden (occult) blood in the stool, which may signal cancer. 'A FIT test is done annually, and is designed to detect hidden blood coming from the colon. It is a noninvasive colorectal cancer detection test, designed to detect colorectal cancer," says Dr. Sophie Balzora, Gastroenterologist at NYU. Other details: FIT does not require any bowel preparation or dietary restrictions, making it a more convenient option. However, it cannot detect precancerous polyps and must be completed annually to remain effective. 6. Guaiac-based Fecal Occult Blood Test What it is: Similar to FIT but uses a different chemical method to detect blood in the stool. 'This has essentially fallen out of favor. There are better screening detection tests available for average-risk individuals," says Balzora. Other details: This test may require dietary changes before stool sample collection. It is recommended annually but is less accurate and largely outdated. 7. Stool DNA Test (e.g. Cologuard) What it is: Stool DNA test combines FIT with a DNA test to detect cancer-related DNA mutations in stool. 'It is done every 3 years assuming a negative test. It, too, is designed to detect colorectal cancer, and not the precancerous growths, or polyps, ' says Balzora. Other details: It requires no dietary restrictions ahead of giving a stool sample. However, positive results necessitate follow-up with a colonoscopy. Colon cancer screening is not a one time event. It needs to be repeated to monitor for interval change in the colon. However, the frequency of screening is variable. 'If someone has many precancerous polyps, even one large polyp (over 1 cm—about the size of a pea), or polyps with certain microscopic features, they are recommended to come in sooner for their next colonoscopy than someone at average risk or with no prior polyps,' says Balzora. Regular screening for colon cancer is a powerful tool in reducing the incidence and mortality associated with the disease. While the gold standard test is a colonoscopy, the right test for you depends on your risk level, personal preferences, and access to testing. Speak with your healthcare provider to determine the most appropriate option and timing. The most important point is to not delay screening.

Investigation finds medications were contributing factor in medical flight crash
Investigation finds medications were contributing factor in medical flight crash

Washington Post

time41 minutes ago

  • Washington Post

Investigation finds medications were contributing factor in medical flight crash

CHELSEA, Ala. — Federal investigators found that a pilot's medication use may have been a contributing factor in a 2023 medical helicopter crash that killed two in Alabama . The National Transportation Safety Board released the final report this month on the April 2, 2023, accident. The Airbus EC130 medical helicopter crashed near the community of Chelsea in Shelby County with the three crew aboard. The pilot and a nurse on the flight were killed.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store